DOI QR코드

DOI QR Code

TNM Stages and Prognostic Features of Colorectal and Mucinous Adenocarcinoma Patients: a Meta Analysis

  • Chen, Jing-Xiang (Department of Emergency, Jiangjin Central Hospital) ;
  • Tang, Xu-Dong (Department of Gastroenterology, Daping Hospitail, Third Military Medical University) ;
  • Xiang, De-Bing (Department of Oncology, Jiangjin Central Hospital) ;
  • Dong, Xiao-Ling (Department of Hepatobiliary Surgery, Jiangjin Central Hospital) ;
  • Peng, Fang-Yi (Department of Clinical Laboratory, Jiangjin Central Hospital) ;
  • Sun, Gui-Yin (Department of Oncology, Jiangjin Central Hospital)
  • 발행 : 2012.07.31

초록

Aim: The significance of the mucinous adenocarcinoma in TNM staging and prognosis for colorectal tumor patients is still controversial. The aim was to provide a meta-analysis for TNM staging and prognostic features of colorectal tumors. Methods: 30 individual case-control studies were finally included into this meta-analysis, involving a total of 444,489 cancer cases and 45,050 mucinous adenocarcinomas, of relations with TNM staging and prognostic features. Results: Compared to non-mucinous adenocarcinoma patients, the TNM IV stage accounted for a larger percentage of mucinous adenocarcinomas (OR=1.48, 95%CI 1.28-1.71, POR<0.001) and the prognosis was significantly poor (HR=1.06, 95%CI 1.04-1.08, P<0.001). After heterogeneity testing, the results was similar to the holistic approach outcome (HR=1.48, 95%CI 1.35-1.62, P<0.001). Conclusion: Compared to patients with non-mucinous adenocarcinomas, mucinous adenocarcinoma patients with later TNM staging make up a big percentage, and mucinous adenocarcinoma is an independent risk factor for poor prognosis.

키워드

참고문헌

  1. Catalano V, Loupakis F, Graziano F, et al (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first- line oxaliplatin- and /or irinotecan-based chemotherapy. Br J Cancer, 100, 881-7. https://doi.org/10.1038/sj.bjc.6604955
  2. Catalano V, Loupakis F, Graziano F, et al (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol, 23, 135-41.
  3. Cerottini JP, Caplin S, Pampallona S, Givel JC (1999). Prognostic factor s in colorectal cancer. Oncol Rep, 6, 409-14.
  4. Chen JS, Hsieh PS, Hung SY, et al (2004). Clinical signifi cance of signet ring cell rectal carcinoma. Int J Colorectal Dis, 19, 102-7. https://doi.org/10.1007/s00384-003-0515-y
  5. Chiang JM, Yeh CY, Changchien CR, et al (2010). Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis, 25, 941-7. https://doi.org/10.1007/s00384-010-0958-x
  6. Consorti F, Lorenzotti A, Midiri G, et al (2000). Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case control study. J Surg Oncol, 73, 70-4. https://doi.org/10.1002/(SICI)1096-9098(200002)73:2<70::AID-JSO3>3.0.CO;2-J
  7. Cusack JC, Giacco GG, Cleary K, et al (1996). Survival factors in 186 patients younger than 40 years old with colorectal ad nocarcinoma. J Am Coll Surg, 183, 105-12.
  8. Du W, Mah JTL, Lee J, et al (2004). Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum, 47, 78-85. https://doi.org/10.1007/s10350-003-0014-9
  9. Enriquez JM, Diez M, Tobaruela E, et al (1998). Clinical, histopatho logical, cytogenetic and prognostic differences between mucinous andnonmucinous colorectal adenocarcinomas. Rev Esp Enferl Dig, 90, 568-72.
  10. Farhat MH, Barada KA, Tawil AN, et al (2008). Effect of mucin productio non survival in colorectal cancer: a case control study. World J Gastroenterol, 14, 6981-5. https://doi.org/10.3748/wjg.14.6981
  11. Ghabeljoo M, Jafarabadi MA, Mohammadi SM, et al (2011). Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran. Asian Pac J Cancer Prev, 12, 1225-31.
  12. Greenson JK, Huang SC, Herron C, et al (2009). Pathologic predictors of microsatellite instability in colorecta l cancer. Am J S urg Pathol, 33, 126-33. https://doi.org/10.1097/PAS.0b013e31817ec2b1
  13. Grillo-Ruggieri F, Mantello G, Berardi R, et al (2007). Mucinousrectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum, 50, 1594-603. https://doi.org/10.1007/s10350-007-9026-1
  14. Hill DA, Furman WL, Billups CA, et al (2007). Colorectal carcinoma in child hood and adolescence: a clinicopathologic review. J Clin Oncol, 25, 5808-14. https://doi.org/10.1200/JCO.2007.12.6102
  15. Huang GL, Guo HQ, Yang F, et al (2012). Activating transcription factor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 13, 1053-7. https://doi.org/10.7314/APJCP.2012.13.3.1053
  16. Hyngstrom JR, Hu C- Y, Xing Y, et al (2012). Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the national cancer data base. Ann Surg Oncol, 2012 Apr 4. [Epub ahead of print]
  17. Jass JR, Sobin LH. Histologic Typing of Intestinal Tumours (1989). 2nd edn. Berlin: Springer-Verlag, 1989.
  18. Jivapaisarnpong P, Boonthongtho K (2011). Clinicopathological characteristics of mucinous and non- mucinous adenocarcinoma in the colon andrectum in Rajavithi Hospital, Thailand. J Med Assoc Thai, 94, S41-5.
  19. Kanemitsu Y, Kato T, Hirai T, et al (2003). Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum, 4, 160-7.
  20. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY (2005). A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum, 48, 1161-8. https://doi.org/10.1007/s10350-004-0932-1
  21. Langner C, Harbaum L, Pollheimer MJ, et al (2012). Mucinous differentiation in colorectal cancer-indicator of poor prognosis? Histopathology, 60, 1060-72. https://doi.org/10.1111/j.1365-2559.2011.04155.x
  22. Lee WS, Chun HK, Lee WY, et al (2007). Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg, 194, 294-8. https://doi.org/10.1016/j.amjsurg.2006.12.041
  23. Min BS, Kim NK, Ko YT, et al (2009). Clinicopathological features of signetring cell carcinoma of the colon and rectum: a case - matched study. Hepatogastroenterology, 56, 984-8.
  24. Negri FV, Wotherspoon A, Cunningham D, et al (2005). Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol, 16, 1305-10. https://doi.org/10.1093/annonc/mdi244
  25. Nozoe T, Anai H, Nasu S, et al (2000). Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol, 75, 103-7. https://doi.org/10.1002/1096-9098(200010)75:2<103::AID-JSO6>3.0.CO;2-C
  26. Pande R, Sunga A, Levea C, et al (2008). Significance of signetring cells in patients with colorectal cancer. Dis Colon Rectum, 51, 50-5. https://doi.org/10.1007/s10350-007-9073-7
  27. Papadopoulos VN, Michalopoulos A, Netta S, et al (2004). Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol, 8, S123-5. https://doi.org/10.1007/s10151-004-0131-z
  28. Safaee A, Moghimi-Dehkordi B, Fatemi SR et al (2010). Characteristics of colorectal mucinous adenocarcinoma in Iran. Asian Pac J Cancer Prev, 11, 1373-5.
  29. Sengul N, Wexner SD, Woodhouse S, et al (2006). Effects of radiotherapy on different histopathological types of rectal carcinoma. Colorectal Dis, 8, 283-8. https://doi.org/10.1111/j.1463-1318.2005.00934.x
  30. Song W, Wu SJ, He YL, et al (2009). Clinicopathologic features and survival of patients with colorectal mucinous, signetring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl), 122, 1486-91.
  31. Sultan I, Rodriguez - Galindo C, El- Taani H, et al (2010). Distinct features of colorectal cancer in children and adolescents a population- based study of 159 cases. Cancer, 116, 758-65. https://doi.org/10.1002/cncr.24777
  32. Sun XF, Carstensen JM, Stal O, et al (1996). Interrelations of clinicopathologic variables and their prognostic value in colorectal adenocarcinoma. APMIS, 104, 35-8.
  33. Verhulst J, Ferdinande L, Demetter P, et al (2012). Mucinous subtype as prognostic factor in colorectal cancer:a systematic review and meta-analysis. J Clin Pathol, 65, 381-8. https://doi.org/10.1136/jclinpath-2011-200340
  34. Wu CS, Tung SY, Chen PC, et al (1996). Clinicopathological study of colorectal muc ino uscarcinoma in Taiwan: a multivariate analysis. J Gastroenterol Hepatol, 11, 77-81. https://doi.org/10.1111/j.1440-1746.1996.tb00014.x
  35. Xie L, Villeneuve PJ, Shaw A (2009). Survival of patients diagnosed with either colorectal mucinous or non - mucinous adenocarcinoma: a population- based study in Canada. Int J Oncol, 34, 1109-15.
  36. Yamaguchi T, Taniguchi H, Fujita S, et al (2012). Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology Mar 27. doi: 10.1111/j.1365-2559.2012.04235.x.
  37. Ye S, Liu X, Wang Q (2002). Colon mucinous adenocarcinoma:107 cases report. J Fujian Med, 24, 12-3.
  38. You JF, Hsieh LL, Changchien CR, et al (2006). Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients. Clin Cancer Res, 12, 4244-50. https://doi.org/10.1158/1078-0432.CCR-06-0202
  39. Zhen M, Li J, Zhou L (2005). Pathological features and prognosis of colon mucinous adenocarcinoma. J China Oncol, 15, 383-6.

피인용 문헌

  1. Mucinous and Signet-Ring Cell Colorectal Cancers Differ from Classical Adenocarcinomas in Tumor Biology and Prognosis vol.258, pp.5, 2013, https://doi.org/10.1097/SLA.0b013e3182a69f7e
  2. Resection of Liver Metastases From Colorectal Mucinous Adenocarcinoma vol.260, pp.5, 2014, https://doi.org/10.1097/SLA.0000000000000981
  3. A Minor (<50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0121944
  4. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer vol.115, pp.7, 2016, https://doi.org/10.1038/bjc.2016.274
  5. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients vol.23, pp.5, 2016, https://doi.org/10.1245/s10434-015-5029-7
  6. Prognostic Significance of Mucinous Histologic Subtype on Oncologic Outcomes in Patients With Colorectal Cancer vol.33, pp.2, 2017, https://doi.org/10.3393/ac.2017.33.2.57